Statistics about Health, Pharma & Medtech in United States
Statistics
- Marijuana Company Of America net cash 2017-2021
- Altimmune net cash 2019-2023
- Marijuana Company Of America liabilities 2017-2021
- Marpai revenue 2021-2023
- Mustang Bio liabilities 2019-2023
- Mustang Bio operating profit 2019-2023
- Marijuana Company Of America operating profit 2017-2021
- Marijuana Company Of America gross profit 2017-2021
- Altimmune net income 2019-2023
- Marijuana Company Of America revenue 2017-2021
- Marijuana Company Of America net income 2020-2021
- Miromatrix Medical Inc. net income 2020-2022
- Mirum Pharmaceuticals net income 2019-2023
- Mink Therapeutics net cash 2020-2023
- Mink Therapeutics total assets 2020-2023
- Mink Therapeutics operating profit 2020-2023
- Mink Therapeutics total equity 2019-2023
- Mink Therapeutics net income 2020-2023
- Miromatrix Medical Inc. revenue 2020-2022
- Zoetis total equity 2019-2023
- Poseida Therapeutics total assets 2019-2023
- Terns Pharmaceuticals liabilities 2020-2023
- Provention Bio, Inc. total assets 2018-2022
- Allarity Therapeutics total assets 2020-2023
- Prelude Therapeutics total assets 2019-2023
- Praxis Precision Medicines total assets 2019-2023
- Pyxis Oncology net cash 2020-2023
- Pulmatrix, Inc. net cash 2019-2023
- Q Biomed net cash 2018-2022
- Prophase Labs total assets 2019-2023
- Protagonist Therapeutics net cash 2019-2023
- Poseida Therapeutics net cash 2019-2023
- Provention Bio, Inc. net cash 2018-2022
- Prophase Labs net cash 2019-2023
- Praxis Precision Medicines net cash 2019-2023
- Prelude Therapeutics net cash 2019-2023
- Novan revenue 2018-2022
- Zoetis net cash 2019-2023
- Allena Pharmaceuticals total equity 2017-2021
- Q Biomed liabilities 2018-2022
- Pulmatrix, Inc. liabilities 2019-2023
- Pyxis Oncology liabilities 2020-2023
- Protagonist Therapeutics liabilities 2019-2023
- Poseida Therapeutics liabilities 2019-2023
- Provention Bio, Inc. liabilities 2018-2022
- Prelude Therapeutics liabilities 2019-2023
- Prophase Labs liabilities 2019-2023
- Coeptis Therapeutics Holdings liabilities 2019-2023
- Praxis Precision Medicines liabilities 2019-2023
- Q Biomed operating profit 2013-2022
- Pyxis Oncology operating profit 2020-2023
- Pulmatrix, Inc. operating profit 2019-2023
- Renovaro Inc. gross profit 2012-2016
- Allakos net cash 2019-2023
- Meridian Bioscience Inc revenue 2018-2022
- Monte Rosa Therapeutics net income 2020-2023
- Caribou Biosciences liabilities 2020-2023
- Thorne Healthtech operating profit 2020-2022
- Theseus Pharmaceuticals, Inc. operating profit 2020-2022
- Monopar Therapeutics operating profit 2019-2023
- Morphic Holding revenue 2019-2023
- Moderna revenue 2019-2023
- Morphic Holding net income 2019-2023
- Monopar Therapeutics net income 2021-2022
- Monte Rosa Therapeutics liabilities 2020-2023
- Monte Rosa Therapeutics total equity 2019-2023
- Monte Rosa Therapeutics total assets 2020-2023
- Monte Rosa Therapeutics operating profit 2020-2023
- Monte Rosa Therapeutics net cash 2020-2023
- Mosaic Immunoengineering Inc. total equity 2019-2023
- Caribou Biosciences net cash 2019-2023
- Mosaic Immunoengineering Inc. liabilities 2019-2023
- Mosaic Immunoengineering Inc. net cash 2018-2023
- Mosaic Immunoengineering Inc. operating profit 2021-2023
- Minerva Neurosciences total equity 2019-2023
- Minerva Neurosciences total assets 2019-2023
- Minerva Neurosciences net cash 2019-2023
- Minerva Neurosciences operating profit 2019-2023
- Minerva Neurosciences liabilities 2019-2023
- Minerva Neurosciences net income 2019-2023
- Myriad Genetics total equity 2019-2023
- Ngm Biopharmaceuticals Inc revenue 2019-2023
- Matinas Biopharma Holdings total equity 2019-2023
- Myriad Genetics total assets 2019-2023
- Twinlab Consolidated Holdings operating profit 2019-2023
- Caribou Biosciences total assets 2020-2023
- Caribou Biosciences net income 2019-2023
- Matinas Biopharma Holdings total assets 2019-2023
- Cartesian Therapeutics, Inc. operating profit 2019-2023
- Akouos, Inc. total assets 2019-2021
- Monopar Therapeutics total assets 2019-2023
- Akouos, Inc. total equity 2018-2021
- Moderna net cash 2019-2023
- Morphic Holding net cash 2019-2023
- Moderna liabilities 2019-2023
- Monopar Therapeutics net cash 2019-2023
- Morphic Holding liabilities 2019-2023
- Akouos, Inc. net cash 2019-2021
- Aldeyra Therapeutics operating profit 2019-2023
- Cartesian Therapeutics, Inc. liabilities 2019-2023